Ads
related to: Treatment Macular Degenerationvisionalivemax.com has been visited by 10K+ users in the past month
Search results
Byooviz dosage: Form, strength, when to use, and more
Medical News Today· 18 hours agoByooviz (ranibizumab-nuna) is a brand-name drug prescribed for certain eye conditions in adults. It...
Ocular Therapeutix™ Announces Positive Topline Phase 1 Data for AXPAXLI™ in Diabetic Retinopathy
Morningstar· 19 hours ago(NASDAQ:OCUL) (“Ocular”), a biopharmaceutical company committed to enhancing people’s vision and quality of life through the development and commercialization of innovative therapies for wet ...
Barclays initiates 4D Molecular stock with Overweight By Investing.com
Investing.com· 4 days agoThe firm's decision is rooted in the promising clinical profile of 4D Molecular Therapeutics'...
REGENXBIO (NASDAQ:RGNX) Stock Price Down 3.1% Following Insider Selling
ETF DAILY NEWS· 5 hours agoREGENXBIO Inc. (NASDAQ:RGNX – Get Free Report)’s share price was down 3.1% on Thursday after an insider sold shares in the company. The company traded as low as $16.21 and last traded at $16.50 ...
Nanoscope Therapeutics to Present at the World Orphan Drug Congress 2024
WJTV Jackson· 2 days ago...Nanoscope Therapeutics Inc., a late-stage clinical biotechnology company developing gene therapies for inherited retinal diseases and age-related macular degenerations (AMD), today announced that Sulagna Bhattacharya, Chief Executive Officer and Samarendra...application of Nanoscope's...
Clearside Biomedical appoints new board member By Investing.com
Investing.com· 3 days agoClearside Biomedical, Inc. (NASDAQ:CLSD), a company focused on developing treatments for eye...
Women of Influence: Health Care 2024 – Deborah Ferrington - Los Angeles Business Journal
Los Angeles Business Journal· 3 days agoRyan – Arnold and Mabel Beckman Foundation Endowed Presidential Chair. Dr. Ferrington’s illustrious...
Regeneron (REGN) Accused of Fraudulent Practices Related to Eylea
Zacks via Yahoo Finance· 7 days agoThe lawsuit was originally filed under the qui tam or whistleblower provisions of the FCA. Eylea is...
The 3 Best Biotech Stocks to Buy Now: Q2 Edition
InvestorPlace· 2 days agoWith innovation, mergers and acquisitions, major companies looking to replenish their pipelines ahead of patent expirations, treatments for obesity,...
Biotech on a Budget: 7 Stocks Under $10 With Huge Potential
InvestorPlace· 4 days agoThe broader medical therapeutic sector is already volatile so it stands to reason in some sense to...
Ad
related to: Treatment Macular Degenerationvisionalivemax.com has been visited by 10K+ users in the past month